Source: Annual Congress 2006 - Hospital-acquired pneumonia: from inflammation to treatment
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. M. Luna, S. Baquero, S. Gando, J. Rizzo Patron, J. Garcia Morato, D. H. Goffredo, R. Absi, A. Famiglietti, C. A. Vay, G. Pargament, F. Von Stecher, O. Sibila, C. Agusti, A. Torres (Buenos Aires, Argentina; Barcelona, Spain). Lung physiology and inflammatory markers in treated and untreated ventilator associated pneumonia (VAP), lessons learned from a porcine model. Eur Respir J 2006; 28: Suppl. 50, 4500

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary apoptosis and related markers in ventilator acquired pneumonia (VAP) Source: Eur Respir J 2003; 22: Suppl. 45, 13s Year: 2003 The role of serum inflammatory markers in the detection of ventilation associated pneumonia (VAP) Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Regulation of PMN apoptosis in the airways during community acquired pneumonia in COPD patients and controls Source: Annual Congress 2006 - Molecular airway biology Year: 2006 Studying lung inflammatory biomarkers using non-invasive methods in patients with community acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP) Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track Year: 2005 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Thyroid function in community-acquired pneumonia (CAP) patients: Pattern, relationship with severity and outcomes, need for invasive mechanical ventilation and vasopressor support Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Lung vessel thrombosis like the reason of mortality at severe community-acquired pneumonia (CAP) of viral and bacterial etiology - autopsy data Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis Source: Eur Respir Rev, 29 (157) 200240; 10.1183/16000617.0240-2020 Year: 2020 Acute respiratory failure (ARF) and severe sepsis (SS) in community acquired pneumonia (CAP): different outcomes? Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Mechanical ventilation interacts with experimental low dose endotoxemia to induce apoptotic lung responses in mice Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005 Precision cut lung slices: A novel method for examining mechanisms underlying respiratory diseases Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Defining stability in pneumonia and the non-responding pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP) Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Ventilator-associated lung injury: a search for better therapeutic targets Source: Eur Respir J 2007; 30: 1216-1226 Year: 2007 Bacterial infection in hospitalized patients of acute exacerbation of COPD and their relation to lung function: A prospective study Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 Ventilator associated pneumonia: the role of bronchoscopy to investigate and to diagnose lung infection Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009